Northwest Health Prop Real Est Inv Trust…

Home

Daily Stock Opinions and Ratings

Northwest Health Prop Real Est Inv Trust (NWH.UN.TO)

5.66

-0.01 (0.18%)

as of Mar 10, 2026, 8:00:00 pm Market Open.

340 watching

Investor Insights

Aug 23, 2026, 12:00 am

This summary was created by AI, based on 9 opinions in the last 12 months.

Northwest Health Prop Real Est Inv Trust (NWH.UN-T) is undergoing a significant transformation under new management, particularly after the replacement of its former CEO who had expanded into international markets. Analysts highlight the company's focus on streamlining operations, selling off non-core assets, and enhancing its presence in North America, particularly in the growing healthcare sector. The firm is viewed as a turnaround story, with potential for increased value realization as they pay down existing debt and concentrate on long-term leases. While the yields remain attractive at around 6-7%, some experts suggest caution, recommending waiting for potential price dips before making investments. There are hints of takeover rumors, potentially adding to future upside.

Consensus

Cautious

Valuation

Fair Value

Similar

OHI

DON'T BUY

Got on the wrong side of managing its debt. Now it's trying to figure out how to service it, with some success. But risk/return is not best way to deploy your capital. Too risky for him.

BUY ON WEAKNESS

Problem with company includes floating rate debt (higher interest rates).
Owns large array of health care real estate assets.
Capital structure and dividend policy not in a good position.
Concerned about potential of dividend cut.

WAIT

Pounded along with a lot of real estate. Quality company. There will be some carnage across real estate, and it's hard to predict the knock-on effects. Be cautious. If you own it, you're not in peril. Otherwise, wait till interest rates have peaked, and you might get it even cheaper.

HOLD

Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.

We would consider results OK. Cash flow per share of 16c did miss estimates of 17c, but revenue of $135M beat estimates of $122M. Payout ratio has risen but on an annual basis was 68% in 2022. Operating income increased, offset by higher rates. Occupancy is good at 97%, leases are long and many are indexed. The convertible issue, the institutional investor and the planned asset sales should add a lot more financial flexibility. The proof will be in the pudding but the comments we think make the point that management knows that leverage and recession concerns are hurting their valuation. We are not sure the corned has been turned, but are more optimistic than pessimistic, largely because of its already-low valuation.
Unlock Premium - Try 5i Free

SELL

Heading down and continues to make new lows. Moving opposite to the TSX, which has turned and is heading higher. Lower lows and lower highs, the definition of a downtrend. Sell your losers.

WATCH

Add now?

Tough. Heavy debt load with variable rate exposure. Good business. Reworking portfolio. Should be stable once they right-size balance sheet, which they're working on. He's watching it. He's not tempted to bottom-fish, wants to see a few better quarters first.

DON'T BUY

Global assets. In a tough spot. Challenges to earnings from interest rates and currency. Great assets. Not for the faint of heart. Not for him today.

DON'T BUY

It owns medical facilities globally. This includes medical office buildings, hospitals, etc. The balance sheet is a bit stretched along with an 8% yield. Another concern is some cash flow disruption due to not hedging currencies.

COMMENT

(NWH does not operate retirement homes.) Rather, they operate hospitals and medical buildings across Canada, Europe, Brazil and Australia. So, they take on currency risk. Their large growth has been financed by variable-rate debt, because NWH felt that these properties could be put into joint ventures--take that JV capital and continues to grow with it, then turn out that debt at that time. The rapid spike in interest rates has caught them off guard. So, they have more risk than the typical. Pays a higher yield, but at a higher payout ratio. Their assets are quality, many being infrastructure.

TOP PICK

High dividend yield (~8%). Current share price presenting good buying opportunity (long term investor). Healthcare properties not sensitive to rising interest rates. Well managed and consistent growth.

DON'T BUY

Its assets are a fantastic way to earn on real estate. Geographically diversified with multiple management teams and dynamics, so it's hard to wrap your head around. Outperformed relative to the sector. He prefers a simpler theme.

BUY ON WEAKNESS

Global medical facilities. Canada, Brazil, Australia, UK, Europe. Shares sold off with failed Australian deal. Stable operator. Premium to NAV. Yield is safe. Bit of currency volatility. Grows nicely, in good shape. Issues equity to fund growth, which provides a time to buy.

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. NAV per unit growth is 6.3% based on strong revaluation gains in Australia and a rebound for Brazilian Real. The growth strategy based on continued revaluation gains and execution in UK value creation initiatives was reiterated by management. Deploying capital for their acquisition. A fine quarter. Unlock Premium - Try 5i Free

WAIT

It's recovered. Trades at a premium to NAV, so they can continue to expand globally and issue debt to do so. Most assets outside Canada. Wait for pullback, probably later this year if they raise equity to close current acquisition in Australia.

WEAK BUY

A diversified healthcare REIT, with assets in Australia, New Zealand, UK, Brazil and Canada. They just issued units to the public, which signals their stock is fairly valued. It trades at a discount to NAV. NWH is very safe, operating in the right segments of healthcare. They have a growing asset management business, providing steady a fee income stream. There's less upside here vs. other healthcare names, and you're owning for the yield.

Showing 31 to 45 of 133 entries

Most Recent Experts

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Josh Brown, CEO, Ritholtz Wealth Management

Ritholtz Wealth Management

Amy Raskin, CIO, Chevy Chase Trust

Chevy Chase Trust

Darren Sissons

Campbell Lee & Ross

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Northwest Health Prop Real Est Inv Trust (NWH.UN.TO)